Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not enough obese subjects could be recruited.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Spaarne Gasthuis | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this pilot study is to determine the feasibility of Do-It-Yourself studies in pregnant women to detect changes in health parameters by assessing compliance and user experiences of participants. Besides, the measured health will be analysed to increase insight in physiological development in pregnant women.
The study is designed as an open, parallel, do-it-yourself, explorative, two-group study. Subjects are women who are pregnant for approximately 3 months at the start of the study. Subjects will be included between week 12 and 15 of their pregnancy (T=-1). Week 16 is the start of the study (T=0). In the first group obese pregnant women (BMI ≥ 30) will be included; the second group will consist of lean pregnant women (BMI 18,5 - 25).
The women will be requested to assess physiological parameters at regular intervals from three months pregnancy until giving birth (week 40). The assessment after giving birth, until three months after giving birth (total study duration of approximately nine months), is optional.
Health parameters are known to be subject to change in pregnant women; the self-monitoring devices should be able to show these changes. Included subjects will be provided with the do-it-yourself devices, manuals and the study protocol. During the nine-month study, the subjects will use these do-it-yourself devices to self-monitor multiple health parameters in an at-home setting. They will be reminded to perform these tests via SMS. There are two frequency intervals defined (two week interval and eight week interval).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Obese pregnant women | 20 obese pregnant women (BMI ≥ 30) | ||
| Lean pregnant women | 20 lean pregnant women (BMI 18,5 - 25) |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| compliance (percentage of complete datasets) | as a measure of the potential of DIY-monitoring in pregnant women | end of study (3 months after giving birth) |
| Capability of and burden for participants of the use of DIY tools | as assessed by a questionnaire on user-experience with do-it-yourself devices in an at-home setting | end of study (3 months after giving birth) |
| Measure | Description | Time Frame |
|---|---|---|
| fasting blood glucose | as measured using a do-it-yourself glucose meter after an overnight fast | at enrollment (between w12-15 of pregnancy), baseline (w16 of pregnancy), w18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40 of pregnancy; optionally after delivery in w42, 44, 46, 48, 50, 52 |
| body weight |
Not provided
Inclusion Criteria:
Pregnant between 12-15 weeks at the start of the study;
Healthy as assessed by the Health and Lifestyle questionnaire (P9624 F02);
Body mass index:
Able to use self-monitoring devices;
Voluntary participation;
Having given written informed consent;
Willing to comply with study procedures;
Willingness to share pseudonymised data on measured health parameters with external parties that provide the measuring devices (including MijnEetmeter, Moves and NRC) for reasons of synchronisation with the study database;
Willing to accept use of all nameless data, including publication, and the confidential use and storage of all data by TNO;
Have internet access at home;
Subjects should own a Smartphone with Bluetooth that runs either a recent version of iOS or Android.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
The study population consists of 40 women who are between 12 and 15 weeks pregnant at the time of inclusion in the study. In this study, two groups will be compared: 20 obese pregnant women (BMI ≥ 30) and 20 lean pregnant women (BMI 18,5 - 25).
All pregnant women will be from Dutch descent (Dutch nationality and culture).
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Marlies A van Houten, Dr. | Spaarne Gasthuis | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Spaarne Gasthuis | Hoofddorp | North Holland | 2134 TM | Netherlands |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009765 | Obesity |
| D010349 | Patient Compliance |
| ID | Term |
|---|---|
| D050177 | Overweight |
| D044343 | Overnutrition |
| D009748 | Nutrition Disorders |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Finger-prick-blood for dried blood spots will be performed for oral glucose tolerance tests (insuline/c-peptide response profile) and determining protein and lipid metabolism as well as HbA1c.
Finger-prick-blood for measurement of glucose and cholesterol using do-it-yourself devices.
Saliva and fecal samples for determining gut and oral microbiota (bacteria) by DNA sequencing of bacterial marker genes present in fecal and saliva samples.
Hair sample for determining cortisol concentrations over time.
as measured by a smart-scale |
| at enrollment (between w12-15 of pregnancy), baseline (w16 of pregnancy), w18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40 of pregnancy; optionally after delivery in w42, 44, 46, 48, 50, 52 |
| physical activity (calories burned, minutes of physical activity, number of steps) | participants continuously wear the activity tracker during the day for the whole week in each of the above mentioned measurement-weeks | at enrollment (between w12-15 of pregnancy), baseline (w16 of pregnancy), w18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40 of pregnancy; optionally after delivery in w42, 44, 46, 48, 50, 52 |
| blood pressure (diastolic, systolic, heart rate) | as measured with a do-it-yourself blood pressure meter | at enrollment (between w12-15 of pregnancy), baseline (w16 of pregnancy), w18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40 of pregnancy; optionally after delivery in w42, 44, 46, 48, 50, 52 |
| GPS location | measured with an app that will be installed on the Smartphone of the participant at enrollment in the study | measured continuously during the entire study |
| Cholesterol (total cholesterol, HDL, LDL, triglycerides, cholesterol/HDL-ratio) | measured using a do-it-yourself cholesterol meter | at enrollment (between w12-15 of pregnancy), baseline (w16 of pregnancy), w24, 32, 40 of pregnancy; optionally after delivery in w52 |
| oral glucose tolerance test (glucose, insulin, c-peptide) | in week 16 the test will be done in a clinical setting; the other tests will be done at home by the participants | baseline (w16 of pregnancy), w24, 32, 40 of pregnancy; optionally after delivery in w52 |
| fecal and salivary microbiota composition | using do-it-yourself sample collection kits (at home by participants; samples will be send to the lab) | at enrollment (between w12-15 of pregnancy), baseline (w16 of pregnancy), w24, 32, 40 of pregnancy; optionally also in w18, 27 and 36, and after delivery in w44, 48 and 52 |
| dried blood spots for HbA1c, fatty acids and blood biomarkers | do-it-yourself using finger-prick and blood spot collection cards that can be send to the lab. | at enrollment (between w12-15 of pregnancy), baseline (w16 of pregnancy), w24, 32, 40 of pregnancy; optionally after delivery in w52 |
| cortisol in hair | measured by taking a hair sample that is send to the lab | at the end of the study (3 months after delivery; week 52) |
| food intake as measured by a web-application | in each measurement week, participants will register their food intake on two week days and one weekend day | at enrollment (between w12-15 of pregnancy), baseline (w16 of pregnancy), w24, 32, 40 of pregnancy; optionally after delivery in w52 |
| cognition | using online cognition tests (on a study portal) | at enrollment (between w12-15 of pregnancy), baseline (w16 of pregnancy), w24, 32, 40 of pregnancy; optionally after delivery in w52 |
| Groninger Sleep Scale | online; can be accessed via the study portal | at enrollment (between w12-15 of pregnancy), baseline (w16 of pregnancy), w24, 32, 40 of pregnancy; optionally after delivery in w52 |
| Vita16 - vitality questionnaire | online; can be accessed via the study portal | at enrollment (between w12-15 of pregnancy), baseline (w16 of pregnancy), w24, 32, 40 of pregnancy; optionally after delivery in w52 |
| visual analogue scales for general health | online; can be accessed via the study portal | at enrollment (between w12-15 of pregnancy), baseline (w16 of pregnancy), w24, 32, 40 of pregnancy; optionally after delivery in w52 |
| D001835 |
| Body Weight |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010342 | Patient Acceptance of Health Care |
| D000074822 | Treatment Adherence and Compliance |
| D015438 | Health Behavior |
| D001519 | Behavior |